INVIRSA INC has a total of 12 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 2017. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are EPIGENESIS PHARMACEUTICALS LLC, STEMGEN S P A and MUNNICH ARNOLD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | United States | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Shalwitz Robert | 11 |
#2 | Ruehlmann Anna Kotsakis | 1 |
#3 | Ruehlmann Anna | 1 |
#4 | Robert Shalwitz | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019191026A2 | Methods for the use of 5'-adenosine diphosphate ribose (adpr) | |
BR112018016398A2 | Methods for using 5'-adenosine diphosphate ribose (adpr) |